Provider review
Nolu review
A named microdose stack, in two variants, billed on a 4-week cycle.
The microdose stack undercuts its own full-dose rates, but every price on the site is billed per 4 weeks, not calendar month.
Price as published
Microdose GLP-1 stack $179/mo — two variants, "Core" and "Energy & Focus" (both GLP-1 + B12 / NAD+) · compounded semaglutide injectable $249/mo · tirzepatide injectable $339/mo · oral semaglutide $279/mo · NAD+/sermorelin from $145/mo · every price is billed per 4 weeks, not calendar month — about 8% higher annualized than the headline figure implies
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The verdict
Nolu sells a genuine, purpose-built Microdose GLP-1+B12/NAD+ stack — offered in two named variants, Core and Energy & Focus — rather than a smaller amount carved out of a standard plan. Everything is priced all-in, with the consultation and shipping folded into one figure and no separate membership stacked on top, which is simpler than most of this board. The catch is the billing cycle: Nolu charges per 4-week period rather than calendar month, so the real annualized cost runs a little above what the headline number suggests, and there is no named clinician or pharmacy behind any of it.
The trade-off we would want you to read first
⚠ Billed per 4-week cycle, not calendar month — the real annualized cost runs roughly 8% above what the $179/$249/$339 headline figures suggest
Who it suits, and who it does not
A good fit if
- You want a purpose-built microdose product rather than a smaller dose of a standard plan
- You'd rather pick a variant (Core, or Energy & Focus) than negotiate a dose with a clinician
- You want one all-in figure with no separate membership fee
- You're comfortable with a 4-week billing cycle rather than a calendar month
Look elsewhere if
- You want the exact annualized cost to be obvious from the monthly headline — the 4-week cycle runs it about 8% higher
- You want a named medical director, prescriber, or compounding pharmacy before you commit
- You're looking for a program built specifically around low-dose, longevity-first framing rather than general wellness branding
How the programme works
Nolu (trynolu.com) is a LegitScript-verified wellness-lifestyle telehealth brand, not positioned around either gender, that sells full-dose compounded semaglutide and tirzepatide alongside a purpose-built Microdose GLP-1+B12/NAD+ stack sold in two named variants — Core and Energy & Focus. Every order is priced all-in (consultation, medication and shipping in one figure, no separate membership fee), which is genuinely simpler than the membership-plus-medication stacking common elsewhere on this board. The one thing to watch is the billing cycle: Nolu bills per 4-week cycle rather than calendar month, so the real annualized cost runs roughly 8% above what the monthly-looking headline number suggests.
At a glance
- Pricing structure
- Flat at every dose
- Consult
- Included in the price
- Compounding
- Not publicly identified
- Labs
- Not required
- Dietitian support
- Not included
Strengths
- A dedicated Microdose GLP-1+B12/NAD+ stack sold as its own named product, in two variants (Core; Energy & Focus) — not a smaller dose of the standard weight-loss plan
- All-in per-order pricing — consultation, medication and shipping in one figure, with no separate membership fee stacked on top
- LegitScript verified, and available in all 50 states plus Washington D.C.
- Both molecules plus an oral semaglutide route, and an adjacent NAD+/sermorelin longevity line from $145/mo
The other trade-offs
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
- No named medical director, prescribers, or compounding pharmacy disclosed anywhere on the site — a real transparency gap for a board built on scrutinizing exactly that
- General wellness-lifestyle branding rather than a specialized low-dose/longevity clinic
Before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Where this sits on the board
Nolu is one of 35 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Funding & disclosures
- A number of links are affiliate or referral links.
- Begin treatment through one and we may earn a commission via the Katalys network — at no added cost to you.
- What we write about a provider is the same either way — unflattering findings about one that pays us stay in.
- Full detail: disclosure page.